You are here

Denamarin by Bioiberica Veterinary is now available in a clinical package

19 Feb 2016
Companion Animal Health

This new product completes our range for hepatic function in animal pets 

Bioiberica Veterinary introduces the Denamarin clinical package, a new product that completes our range of hepatic products, composed so far by Denosyl, the Denamarin tablet bottle and Denamarin blisters.

This new package is sold in 200-tablet boxes which can cover the needs of pets of any size, from cats and small dogs to the largest dog breeds. 

The tablets come in 10-tablet blisters. Furthermore, the display case contains 8 dispensers, which can be individualized depending on the precise treatment for each pet. In this way, veterinarians can tailor the duration and monitoring of treatments, reducing the need of having different packages in stock and improving the cost per treatment ratio.

Cases of cats and dogs suffering from liver disease, especially when they are old, are common in veterinary clinics. Denamarin is the product of choice for the management of hepatopathies, and is especially recommended in acute liver failure cases or in cases where the disease is associated with inflammation. Its concentration of active principia, high safety profile and excellent taste makes Denamarin the ideal product for the treatment of liver failure in pets. 

The new package makes easier to prolong the treatment, adapting the product to the pets’ needs, depending on the veterinarian’ criteria.

Related News

Premio atopivet
4 Oct 2023
Companion Animal Health

This year's winning product was DermalEase/Atopivet drops and mousse - a topical skin care solution.

6 Sep 2023
Companion Animal Health

Pet food is constantly evolving, with new and innovative products being introduced to promote a healthier and more conscious nutrition for pets.

27 May 2020
Companion Animal Health
  • This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
  • The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®